At a glance · for buyers and watchdogs
BRISTOL-MYERS SQUIBB PHARMACEUTICALS LIMITED has won £188.9m across 6 public-sector buyers, with 20 live contracts. No active Companies House risk flags.
Why: top buyer NHS England at 94% · 0 active risk flags · 0 modifications.
ESG & policies vault · 0/5
Key governance & sustainability policies. Published documents link out; missing ones are greyed.
Capabilities
What this supplier does, where they sit, who they sell to.
- NHS England Framework Agreement: South of England (Tranche B)
- NHS England Framework Agreement - London - Tranche A
- NHS Framework Agreement for Proprietary Pharmaceuticals - South of England (Tranche A)
- NHS England - Midlands and East Branded Medicines - Tranche B
- NHS Framework Agreement for Branded medicines - London - Tranche B - Contracts Finder Opportunity
- NHS England Framework Agreement: Midlands and East (Tranche A)
Extracted automatically from bms.com on Jul 2026. Not independently verified — treat as the supplier’s own marketing claims.
Case studies
Delivery stories the supplier has published, with sector and outcome.
No case studies yet
Once a claimed supplier publishes delivery stories — the buyer, the sector, what was delivered and the outcome — they appear here.
Buyer references
Named public-sector contacts who have agreed to act as a reference.
No buyer references yet
Public-sector buyers can confirm they'll act as a reference for this supplier. Confirmed references — with the contract they relate to — show here.
Accreditations & memberships
Independently issued. Verification dates cross-checked against issuer registers.
No accreditations recorded
B-Corp, ISO, Cyber Essentials, Living Wage and similar credentials appear here once added by a claimed supplier and cross-checked against the issuing register.
KPI performance
Delivery, budget and satisfaction scores reported quarterly by buyers.
No verified KPI scores yet
Once buyers report contract KPIs — delivery on time, on budget, satisfaction, adoption and accessibility — a weighted grade and breakdown appear here.
Contracts · 20 live · 20 historic
Pulled from Contracts Finder & Find a Tender. Most recent first.
| Title | Buyer | CPV | Awarded | Value | Term | Status |
|---|---|---|---|---|---|---|
| BELFAST HEALTH AND SOCIAL CARE TRUST | — | 06 Jul 2026 | £3.3m | 2 yrs | Live | |
| BELFAST HEALTH AND SOCIAL CARE TRUST | — | 06 Jul 2026 | £2.0m | 2 yrs | Live | |
| NHS England | 33600000 | 01 Sept 2020 | £6.8m | 2 yrs | Closed | |
| NHS England | 33600000 | 01 Mar 2020 | £5.6m | 2 yrs | Closed | |
| NHS England | 33600000 | 01 Mar 2020 | £15.5m | 2 yrs | Closed | |
| NHS England | 33600000 | 01 Sept 2019 | £7.2m | 2 yrs | Closed | |
| NHS England | 33600000 | 01 Sept 2019 | £8.4m | 12 mo | Closed | |
| NHS England | 33600000 | 01 May 2019 | £18.5m | 2 yrs | Closed | |
| NHS England | 33600000 | 01 Mar 2019 | £9.2m | 2.1 yrs | Closed | |
| NHS England | 33600000 | 01 Mar 2019 | £9.2m | 2.1 yrs | Closed |
Top buyers · 6 buyers · top 3 = 100%
Share of awarded value. Concentration fires above 40% for any single buyer.
Geography
Distribution of awarded value by buyer region.
Peers
Suppliers with overlapping CPVs & buyers (last 24m). BRISTOL-MYERS SQUIBB PHARMACEUTICALS LIMITED highlighted.
| Supplier | SME? | Awarded · 24m | Contracts |
|---|---|---|---|
| Yes | £121.0m | 22 | |
| Yes | £117.6m | 18 | |
| Yes | £95.2m | 12 | |
| Yes | £72.5m | 12 | |
| Yes | £71.2m | 21 | |
BS BRISTOL-MYERS SQUIBB PHARMACEUTICALS LIMITED | Yes | £5.3m | — |
Red flags · 0 active
Automated scan of Companies House status, charges and insolvency records.
Compliance scorecard
Derived from Companies House filings — not a full supplier-assurance check.
Modifications
Variations to awarded contracts logged under Procurement Act 2023 s.74.
No modifications recorded
No published contract variations for this supplier. Modification notices appear here as they are issued under the Procurement Act 2023.
News mentions
UK trade press & nationals, matched to this supplier.
No news mentions found
We haven't matched any recent UK press coverage to this supplier. Mentions appear here automatically as they're published.
Companies House
Live sync — registered details, directors, PSC and SIC codes.
Registered details
- Company no.
- 02487574
- Status
- Active
- Type
- Private limited
- Incorporated
- 02 Apr 1990
- Reg. office
- Arc Uxbridge Sanderson Road, New Denham, Denham, Buckinghamshire, UB8 1DH
- SIC codes
- 21100
- Last accounts
- 31 Dec 2024
- Next accounts due
- 30 Sept 2026
Directors & PSC
- OLIVER, Guy Edward — directorAppointed 11 Mar 2024
- ONG, Annie — directorAppointed 03 Apr 2023
- Bristol-Myers Squibb Holdings 2002 Limited — person with significant controlownership of shares 75 to 100 percent · voting rights 75 to 100 percent · right to appoint and remove directors
Financial
Filed accounts from Companies House.
No financial filings on record
Turnover, profit and headcount appear here once audited or micro-entity accounts are filed at Companies House.
Org tree
Group structure and ownership.
Independent. No parent company or subsidiaries recorded at Companies House for this entity.
Social value · 2/5
Commitments mapped to the Government Social Value Model themes. Each is tagged self-reported or from the website.
Extracted automatically from bms.com on Jul 2026. Not independently verified — treat as the supplier’s own marketing claims.